Masanori Aikawa/LinkedIn
Nov 10, 2026, 13:10
Masanori Aikawa: NEK7 Research Earns Top Honors at AHA 2026
Masanori Aikawa, Professor of Medicine at Harvard Medical School, Chief Editor at Frontiers in Cardiovascular Medicine, shared a post on LinkedIn:
“My superstar postdoc Yuto Nakamura received the Early Career Award for Outstanding Research at the American Heart Association Scientific Sessions 2026 for his groundbreaking work on the role of NEK7 in macrophage inflammasome activation and atherogenesis.
His innovative study earned the highest score!
Congratulations, Yuto! Thank you for your tremendous dedication and hard work! So proud of you.”
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery